Target intelligence / Profile preview

Beta-1,4-N-acetyl-galactosaminyltransferase 4 (B4GALNT4)

Target
B4GALNT4
Molecular classification
Enzyme, Glycosyltransferase, Chondroitin N-acetylgalactosaminyltransferase family
01

Overview

Beta-1,4-N-acetyl-galactosaminyltransferase 4 (B4GALNT4) is an enzyme encoded by the B4GALNT4 gene, classified as a glycosyltransferase that catalyzes the transfer of N-acetylgalactosamine (GalNAc) from UDP-GalNAc to N-acetylglucosamine-β-benzyl via a beta-1,4-linkage, resulting in the formation of N,N'-diacetyllactosediamine in N-linked and probably O-linked glycans. The enzyme is predicted to localize to the Golgi cisterna membrane, where it plays a critical role in protein glycosylation, influencing protein maturation and function. B4GALNT4 belongs to the chondroitin N-acetylgalactosaminyltransferase family and is related to B4GALNT3, sharing similar biochemical activities. While glycosyltransferases are implicated in various biological processes and diseases, direct links between B4GALNT4 and human pathologies are still being elucidated. There are currently no drugs or clinical biomarkers targeting B4GALNT4 specifically described in the accessible scientific literature and databases.

Other names
NGalNAc-T1N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1Beta-1,4-N-acetylgalactosaminyltransferase IVBeta4GalNAc-T4FLJ25045Beta4GalNAcT4betaGT4
02

Biological functions

Glycosylation of proteins (N-linked and likely O-linked glycans)Synthesis of N,N'-diacetyllactosediamine (GalNAc-beta-1,4-GlcNAc structures)Formation of specific glycan structures necessary for protein function and localization
03

Disease associations

Other (no direct disease associations currently confirmed in search results; glycosyltransferases may implicate in cancer, immune response, and other glycosylation disorders, but specifics for B4GALNT4 are not consistently reported)

Beyond the preview

Go deeper on Beta-1,4-N-acetyl-galactosaminyltransferase 4 (B4GALNT4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-1,4-N-acetyl-galactosaminyltransferase 4 (B4GALNT4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call